Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 4,613 | 1,957 | 2,515 | 88,968 | 1,148 |
| Gross Profit | 4,613 | 1,957 | 2,515 | 88,968 | 1,148 |
| Operating Expenses | 129,086 | 128,987 | 110,956 | 99,842 | 79,005 |
| Operating Income | -124,473 | -127,030 | -108,441 | -10,874 | -77,857 |
| Interest Expense | 13,241 | 16,269 | 15,767 | 9,810 | 9,310 |
| Other Income | 6,425 | 5,919 | -18,102 | 864 | -2,278 |
| Pre-tax Income | -131,289 | -137,380 | -142,310 | -19,820 | -89,445 |
| Net Income Continuous | -131,289 | -137,380 | -142,310 | -19,820 | -89,445 |
| Net Income | $-131,289 | $-137,380 | $-142,310 | $-19,820 | $-89,445 |
| EPS Basic Total Ops | -1.38 | -1.53 | -1.52 | -0.23 | -1.05 |
| EPS Basic Continuous Ops | -1.38 | -1.53 | -1.52 | -0.23 | -1.05 |
| EPS Diluted Total Ops | -1.38 | -1.53 | -1.52 | -0.23 | -1.05 |
| EPS Diluted Continuous Ops | -1.38 | -1.53 | -1.52 | -0.23 | -1.05 |
| EBITDA(a) | $-122,625 | $-125,372 | $-107,033 | $-9,467 | $-76,516 |